[CLINICAL AND BIOCHEMICAL OBSERVATIONS ON A COMBINATION OF ETHINYL ESTRENOL AND MESTRANOL (LYNDIOL)].
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004338:Drug Combinations; D004358:Drug Therapy; D045166:Estradiol Congeners; D004967:Estrogens; D005260:Female; D006801:Humans; D008234:Lynestrenol; D008599:Menstruation Disturbances; D008656:Mestranol; D010060:Ovulation; D011276:Pregnanediol; D011279:Pregnanetriol; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004338:Drug Combinations; D045166:Estradiol Congeners; D004967:Estrogens; D011279:Pregnanetriol; C002746:Noracycline; D008656:Mestranol; D011276:Pregnanediol; D008234:Lynestrenol
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; DRUG THERAPY; ESTROGENS; LYNESTRENOL; MENSTRUATION DISORDERS; MESTRANOL; OVULATION; PREGNANEDIOL; PREGNANETRIOL; URINE
KLINISCHE UND BIOCHEMISCHE BEOBACHTUNGEN MIT EINEM ATHINYLOESTRENOL-MESTRANOL-KOMBINATIONSPRAEPARAT (LYNDIOL)